Researchers at MD Anderson discussed the five possible approaches to treating graft-versus-host disease in a review article ...

Dublin, May 19, 2025 (GLOBE NEWSWIRE) -- The "Graft Versus Host Disease (GVHD) - Global Clinical Trials Review, 2025" has been added to ResearchAndMarkets.com's offering. The report offers a ...

Join Drs Tania Jain and Rachel Salit as they explore evolving definitions of remission, relapse monitoring, and ...

Northwell Health unveiled a $1.1 million, 2,400-square-foot expansion of outpatient infusion at the R.J. Zuckerberg Cancer ...

Regarding the pediatric population, mold-active antifungal prophylaxis is recommended for pediatric patients at high risk of IFD, including a subgroup of children with ALL.

Non-dilutive NIH funding supports development of MiNK’s allogeneic iNKT platform for immune regulation in high-risk HSCT ...

Texas A&M’s Simrit Parmar partners with Saudi hospital for groundbreaking cell therapy trials targeting ALS and aplastic ...

The SMC has also has accepted Cladribine, also known as Mavenclad, for the treatment of relapsing-remitting multiple ...